News: Salix Pharmaceuticals Ltd (SLXP.OQ)

SLXP.OQ on NASDAQ Stock Exchange Global Select Market

127.89USD
28 Jan 2015
Change (% chg)

-- (--)
Prev Close
$127.89
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
645,234
52-wk High
$172.97
52-wk Low
$86.00

Search Stocks
Select another date:

Wed, Jan 28 2015

Salix Pharma to restate past seven quarters' results

- Salix Pharmaceuticals Ltd said it would restate financial statements for all of 2013 and the first three quarters of 2014, adding to the drugmaker's list of woes.

UPDATE 1-Salix Pharma to restate past seven quarters' results

Jan 28 - Salix Pharmaceuticals Ltd said it would restate financial statements for all of 2013 and the first three quarters of 2014, adding to the drugmaker's list of woes.

Salix Pharma to restate past seven quarters' results

Jan 28 - Salix Pharmaceuticals Ltd said it will restate its financial statements for all of 2013 and the first three quarters of 2014 due to errors relating to, among others, the timing of revenue recognition.

Exclusive: Salix Pharma working with advisers to explore options - sources

- Salix Pharmaceuticals Ltd , a maker of bowel drugs, is working with investment bank Centerview Partners Holdings LP to explore its options, including a potential sale to a larger drugmaker, according to three people familiar with the matter.

Exclusive: Paulson & Co takes stake in Salix on heels of inventory issues - sources

- Hedge fund Paulson & Co has taken a stake in specialty pharmaceuticals company Salix Pharmaceuticals Ltd as the company recovers from inventory issues and the departure of its chief financial officer, according to people familiar with the matter.

EXclusive: Paulson & Co takes stake in Salix on heels of inventory issues - sources

- Hedge fund Paulson & Co has taken a stake in specialty pharmaceuticals company Salix Pharmaceuticals Ltd as the company recovers from inventory issues and the departure of its chief financial officer, according to people familiar with the matter.

Salix to clear excess inventory earlier than expected

- Salix Pharmaceuticals Ltd said it would clear excess inventory by the end of 2015, a year earlier than it had forecast, sending its shares up about 6 percent premarket.

UPDATE 1-Salix to clear excess inventory earlier than expected

Dec 16 - Salix Pharmaceuticals Ltd said it would clear excess inventory by the end of 2015, a year earlier than it had forecast, sending its shares up about 6 percent premarket.

Salix to fix inventory pile-up by end of 2015

Dec 16 - Salix Pharmaceuticals Ltd said it would cut sales to wholesalers to fix an inventory issue related to three key drugs, and withdrew its forecast for the fourth quarter.

US STOCKS-Wall St ends flat; healthcare off on new Obamacare challenge

* October jobs growth short of forecast but Aug, Sept revised up

Select another date:
Search Stocks